{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:21:09Z","timestamp":1773210069679,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018528","name":"Liuzhou Science and Technology Project","doi-asserted-by":"publisher","award":["2024YB0101A001"],"award-info":[{"award-number":["2024YB0101A001"]}],"id":[{"id":"10.13039\/501100018528","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2024GXNSFAA010075"],"award-info":[{"award-number":["2024GXNSFAA010075"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.urolonc.2025.09.007","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:30:22Z","timestamp":1759008622000},"page":"70.e21-70.e30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the tumor-promoting function and prognostic value of ESPL1 in prostate adenocarcinoma"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4738-6614","authenticated-orcid":false,"given":"Xuemei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8422-0644","authenticated-orcid":false,"given":"Yuzhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10437","key":"10.1016\/j.urolonc.2025.09.007_bib0001","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet Commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet."},{"issue":"10305","key":"10.1016\/j.urolonc.2025.09.007_bib0002","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","article-title":"Prostate cancer","volume":"398","author":"Sandhu","year":"2021","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.urolonc.2025.09.007_bib0003","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899184","article-title":"Local activation of mammalian separase in interphase promotes double-strand break repair and prevents oncogenic transformation","volume":"37","author":"Hellmuth","year":"2018","journal-title":"Embo j"},{"issue":"7431","key":"10.1016\/j.urolonc.2025.09.007_bib0004","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature11630","article-title":"Post-replicative repair involves separase-dependent removal of the kleisin subunit of cohesin","volume":"493","author":"McAleenan","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.urolonc.2025.09.007_bib0005","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1158\/1078-0432.CCR-08-2454","article-title":"Overexpression and mislocalization of the chromosomal segregation protein separase in multiple human cancers","volume":"15","author":"Meyer","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2025.09.007_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1138077","article-title":"Pan-cancer analysis and experimental validation identify the oncogenic nature of ESPL1: potential therapeutic target in colorectal cancer","volume":"14","author":"Zhong","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.09.007_bib0007","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/1354750X.2024.2339288","article-title":"Upregulation of ESPL1 is associated with poor prognostic outcomes in endometrial cancer","volume":"29","author":"Yang","year":"2024","journal-title":"Biomarkers"},{"issue":"4","key":"10.1016\/j.urolonc.2025.09.007_bib0008","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/brv.12321","article-title":"Biology and insights into the role of cohesin protease separase in human malignancies","volume":"92","author":"Zhang","year":"2017","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"35","key":"10.1016\/j.urolonc.2025.09.007_bib0009","doi-asserted-by":"crossref","first-page":"13033","DOI":"10.1073\/pnas.0801610105","article-title":"Overexpression of Separase induces aneuploidy and mammary tumorigenesis","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"issue":"4","key":"10.1016\/j.urolonc.2025.09.007_bib0010","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-2184.2008.00540.x","article-title":"Effect of separase depletion on ionizing radiation-induced cell cycle checkpoints and survival in human lung cancer cell lines","volume":"41","author":"Sak","year":"2008","journal-title":"Cell Prolif"},{"key":"10.1016\/j.urolonc.2025.09.007_bib0011","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12935-020-01230-x","article-title":"A Gleason score-related outcome model for human prostate cancer: a comprehensive study based on weighted gene co-expression network analysis","volume":"20","author":"Wang","year":"2020","journal-title":"Cancer Cell Int"},{"issue":"8","key":"10.1016\/j.urolonc.2025.09.007_bib0012","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1073\/pnas.0730733100","article-title":"Processing, localization, and requirement of human separase for normal anaphase progression","volume":"100","author":"Chestukhin","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"issue":"48","key":"10.1016\/j.urolonc.2025.09.007_bib0013","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1038\/onc.2013.493","article-title":"MMTV-Espl1 transgenic mice develop aneuploid, estrogen receptor alpha (ER\u03b1)-positive mammary adenocarcinomas","volume":"33","author":"Mukherjee","year":"2014","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.urolonc.2025.09.007_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e31192","article-title":"The upregulation and transcriptional regulatory mechanisms of extra spindle pole bodies like 1 in bladder cancer: an immunohistochemistry and high-throughput screening evaluation","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/j.urolonc.2025.09.007_bib0015","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1111\/cas.14991","article-title":"Functional analysis of LAT3 in prostate cancer: its downstream target and relationship with androgen receptor","volume":"112","author":"Rii","year":"2021","journal-title":"Cancer Sci"},{"issue":"8","key":"10.1016\/j.urolonc.2025.09.007_bib0016","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.7150\/thno.82995","article-title":"PER2 integrates circadian disruption and pituitary tumorigenesis","volume":"13","author":"Guo","year":"2023","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.urolonc.2025.09.007_bib0017","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.apsb.2024.12.037","article-title":"BRD4 regulates m(6)A of ESPL1 mRNA via interaction with ALKBH5 to modulate breast cancer progression","volume":"15","author":"Zhang","year":"2025","journal-title":"Acta Pharm Sin B"},{"issue":"10","key":"10.1016\/j.urolonc.2025.09.007_bib0018","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ncb1303","article-title":"Multiple roles for separase auto-cleavage during the G2\/M transition","volume":"7","author":"Papi","year":"2005","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.09.007_bib0019","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.devcel.2012.06.015","article-title":"Separase sensor reveals dual roles for separase coordinating cohesin cleavage and cdk1 inhibition","volume":"23","author":"Shindo","year":"2012","journal-title":"Dev Cell"},{"key":"10.1016\/j.urolonc.2025.09.007_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.930647","article-title":"Extra spindle pole bodies-like 1 serves as a prognostic biomarker and promotes lung adenocarcinoma metastasis","volume":"12","author":"Nie","year":"2022","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.urolonc.2025.09.007_bib0021","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1007\/s00210-024-03061-3","article-title":"PAX2 mediated upregulation of ESPL1 contributes to cisplatin resistance in bladder cancer through activating the JAK2\/STAT3 pathway","volume":"397","author":"Zhang","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.09.007_bib0022","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12935-024-03233-4","article-title":"Genome-wide CRISPR screen identifies ESPL1 limits the response of gastric cancer cells to apatinib","volume":"24","author":"Zhang","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"12","key":"10.1016\/j.urolonc.2025.09.007_bib0023","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s12033-022-00511-2","article-title":"Let-7c-5p restrains cell growth and induces apoptosis of lung adenocarcinoma cells via targeting ESPL1","volume":"64","author":"Liu","year":"2022","journal-title":"Mol Biotechnol"},{"issue":"6","key":"10.1016\/j.urolonc.2025.09.007_bib0024","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/1087057114520972","article-title":"Identification and characterization of separase inhibitors (Sepins) for cancer therapy","volume":"19","author":"Zhang","year":"2014","journal-title":"J Biomol Screen"},{"issue":"18","key":"10.1016\/j.urolonc.2025.09.007_bib0025","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1016\/j.bmcl.2016.07.080","article-title":"Synthesis and activity of benzimidazole-1,3-dioxide inhibitors of separase","volume":"26","author":"Do","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.urolonc.2025.09.007_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152730","article-title":"Toxicity study of separase inhibitor-sepin-1 in Sprague-Dawley rats","volume":"216","author":"Zhang","year":"2020","journal-title":"Pathol Res Pract"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925003564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925003564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:30:07Z","timestamp":1773131407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925003564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1078143925003564"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.09.007","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the tumor-promoting function and prognostic value of ESPL1 in prostate adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}